BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/24/2017 11:18:00 AM | Browse: 1250 | Download: 2172
 |
Received |
|
2016-11-18 09:36 |
|
Peer-Review Started |
|
2016-11-23 08:33 |
|
To Make the First Decision |
|
2016-12-29 08:35 |
|
Return for Revision |
|
2016-12-30 10:11 |
|
Revised |
|
2017-01-28 03:12 |
|
Second Decision |
|
2017-03-02 18:03 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-03-13 12:00 |
|
Articles in Press |
|
2017-03-13 12:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-04-19 08:07 |
|
Publish the Manuscript Online |
|
2017-04-24 11:18 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kathryn E Hitchcock, R Charles Nichols, Christopher G Morris, Debashish Bose, Steven J Hughes, John A Stauffer, Scott A Celinski, Elizabeth A Johnson, Robert A Zaiden, Nancy P Mendenhall and Michael S Rutenberg |
| Funding Agency and Grant Number |
|
| Corresponding Author |
R Charles Nichols, MD, Department of Radiation Oncology, University of Florida, 2015 North Jefferson St. Jacksonville, FL 32206, United States. rnichols@floridaproton.org |
| Key Words |
Pancreatic cancer; Pancreatectomy; Pancreas; Proton therapy; Radiotherapy |
| Core Tip |
Patients undergoing pancreatectomy for rese¬ctable pancreas cancers have a significant risk of local and regional recurrence. That risk could be reduced if patients received moderate-dose preoperative radio¬therapy. Many surgeons, however, are concerned that conventional X-ray-based radiotherapy could com¬plicate what is already a complicated operation. The current series documents the surgical outcomes for 15 patients with initially unresectable pancreatic cancers who underwent pancreatectomy after high-dose [59.40 Gy (RBE)] proton-based radiotherapy. The lack of increased surgical toxicity suggests that proton radiotherapy may represent an optimal vehicle for the delivery of moderate dose neoadjuvant radiotherapy in the setting of resectable disease. |
| Publish Date |
2017-04-24 11:18 |
| Citation |
Hitchcock KE, Nichols RC, Morris CG, Bose D, Hughes SJ, Stauffer JA, Celinski SA, Johnson EA, Zaiden RA, Mendenhall NP, Rutenberg MS. Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer. World J Gastrointest Surg 2017; 9(4): 103-108 |
| URL |
http://www.wjgnet.com/1948-9366/full/v9/i4/103.htm |
| DOI |
http://dx.doi.org/10.4240/wjgs.v9.i4.103 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
